Galmarini C M, Kamath K, Vanier-Viornery A, Hervieu V, Peiller E, Falette N, Puisieux A, Ann Jordan M, Dumontet C
INSERM 590-Laboratoire de Cytologie Analytique, Faculté de Médécine Rockefeller, Lyon 69373, France.
Br J Cancer. 2003 Jun 2;88(11):1793-9. doi: 10.1038/sj.bjc.6600960.
In the present study, we compared the dynamics and composition of microtubules in cell lines derived from the human breast adenocarcinoma MCF-7 containing either the wild-type p53 (wt-p53; MN1) or a dominant-negative variant of p53 gene (mut-p53; MDD2). Mut-p53 cells were significantly resistant to the cytotoxicity of the microtubule-targeted drugs (vinca alkaloids and taxanes), as compared with wt-p53 cells. Studies by high-resolution time-lapse fluorescence microscopy in living cells indicated that the dynamics of microtubules of mut-p53 cells were altered in complex ways and were significantly increased as compared with microtubules in wt-p53 cells. The percentage of time microtubules spent in growing and shortening phases increased significantly, their catastrophe frequency increased, and their overall dynamicity increased by 33%. In contrast, their shortening rate and the mean length shortened decreased. Cells containing mut-p53 displayed increased polymerisation of tubulin, increased protein levels of the class IV beta-tubulin isotype, STOP and survivin, and reduced protein levels of class II beta-tubulin isotype, MAP4 and FHIT. We conclude that p53 protein may contribute to the regulation of microtubule composition and function, and that alterations in p53 function may generate complex microtubule-associated mechanisms of resistance to tubulin-binding agents.
在本研究中,我们比较了源自人乳腺腺癌MCF-7的细胞系中微管的动力学和组成,这些细胞系分别含有野生型p53(wt-p53;MN1)或p53基因的显性负变体(mut-p53;MDD2)。与wt-p53细胞相比,mut-p53细胞对微管靶向药物(长春花生物碱和紫杉烷)的细胞毒性具有显著抗性。通过对活细胞进行高分辨率延时荧光显微镜研究表明,mut-p53细胞微管的动力学以复杂方式改变,与wt-p53细胞中的微管相比显著增加。微管在生长和缩短阶段所花费时间的百分比显著增加,其灾难频率增加,整体动态性增加了33%。相比之下,它们的缩短速率和缩短的平均长度降低。含有mut-p53的细胞显示微管蛋白聚合增加、IV类β-微管蛋白亚型、STOP和存活素的蛋白质水平增加,以及II类β-微管蛋白亚型、MAP4和FHIT的蛋白质水平降低。我们得出结论,p53蛋白可能有助于微管组成和功能的调节,并且p53功能的改变可能产生与微管相关的复杂机制,导致对微管蛋白结合剂产生抗性。